A new technique has been developed that decreases the expenses associated with drug manufacturing while simultaneously improving the stability of pharmaceuticals.
A revolutionary blood test for Alzheimer’s disease is expected to be introduced in Australia soon, aiming to enhance diagnostic methods for the condition.